Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Motor Neurone Disease (MND) is a chronic progressive neurological condition where people experience weakness of muscles leading to pain and restriction of movement as well as problems with swallowing, breathing and communication. The purpose of this study is to establish if Virtual Reality is useful for people with MND and if it helps improve their well being.
Motor Neurone Disease (MND) is a chronic progressive neurological condition where people experience weakness of muscles leading to pain and restriction of movement as well as problems with swallowing, breathing and communication.
As people become increasingly immobile, they become restricted in their ability to perform activities of daily living, access the outdoors, participate in preferred occupational roles or engage in leisure activities. Consequently, there is a deterioration in their ability to experience well being and have quality of life. There is also a significant carer burden as the carer spends long hours in the day looking after the person. The average disease trajectory lasts between 3-5 years, followed by death. More recently, the use of Virtual Reality (VR) technology is being recognised in the field of health. This technology uses the interactions between an individual and a computer generated environment to stimulate different sensory modalities such as visual and auditory. The technology can be accessed commonly using head mounted goggles or head sets. The entertaining or stimulating effect of VR is useful in redirecting the person's attention away from the distressing experiences, such as pain and anxiety. The purpose of this study is to establish if VR is useful for people with MND and if it helps improve their well being.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intervention | Experimental | The intervention period will last 4 weeks where participants will be required to use the VR set and document the time of use in a daily diary |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Virtual Reality Headset | Device | Virtual Reality Headset |
|
| Measure | Description | Time Frame |
|---|---|---|
| Edinburgh Mental Well being Scale | Quality of Life (Scale 0-10 higher being better) | 4 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| ECAS (Edinburgh Cognition Assessment Scale) | Cognition measure scale varied per question (Scale 0-8, 0-10, 0-12 higher being better) | 4 weeks |
| PHQ-9 | scale for depression (Scale 0-27 - higher being worse) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Malabika Ghosh, PhD | Lancashire Teaching Hospitals NHS Foundation Trust | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Lancashire Teaching Hospitals NHS Foundation Trust | Preston | United Kingdom |
No individual participant data will be shared
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot | Yes | No | No | Study Protocol | Jan 7, 2020 | Feb 4, 2022 | Prot_000.pdf |
Not provided
| ID | Term |
|---|---|
| D016472 | Motor Neuron Disease |
| ID | Term |
|---|---|
| D019636 | Neurodegenerative Diseases |
| D009422 | Nervous System Diseases |
| D009468 | Neuromuscular Diseases |
Not provided
Not provided
Device Feasibility
Not provided
Not provided
Not provided
Not provided
| 4 weeks |
| GAD-7 | scale for anxiety (Scale 0-3 where higher is worse outcome) | 4 weeks |
| ALS-FRS | test of function (Yes or No - ability to perform function) | 4 weeks |